Vaccine News and Research

Latest Vaccine News and Research

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

A recent study reports neutralizing efficacy for a fused peptide-antibody molecule against SARS-CoV-2, providing hope that therapeutic neutralizing antibodies may soon be available.

3 Dec 2021

Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

The current study used VHA electronic health records (EHR) to estimate the effectiveness of the booster dose in the USA against post-vaccination COVID-19.

3 Dec 2021

Modeling emergence and dynamics of new COVID-19 variants in the UK

Computer simulations describe global features observed in the daily number of cases and can be applied to any country of interest.

3 Dec 2021

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

...

2 Dec 2021

Link between tobacco product use and alcohol consumption with anti-SARS-CoV-2 antibody titers after BNT162b2 vaccine

In a Japanese study, smoking, HNB tobacco products, and alcohol use have been shown to impair the immunological response to the COVID-19 vaccination.

2 Dec 2021

£700 million will help hospitals across England tackle waiting lists and improve care

Hospitals across the country will benefit from a share of £700 million to expand wards, install modular operating theaters, upgrade outpatient spaces and MRI and screening technology, to help reduce waiting lists.

2 Dec 2021

Government signs new contracts to secure the supply of vaccine stock in light of new variant

The government has signed new contracts to secure the supply of our vaccine stock to future proof the country's vaccine programme.

2 Dec 2021

Most U.S. states failed to prioritize cancer patients for COVID-19 vaccine rollout

Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations, despite recommendations from the Centers for Disease Control and Prevention, according to a study being presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2021

Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

Researchers investigate the antiviral activities of SSPS extracted from green seaweed Ulva sp. to demonstrate the anti-SARS-CoV-2 activity of ulvans.

2 Dec 2021

‘Boost Day’ drive launches to mark one year since COVID-19 vaccine approval in the UK

The UK is marking one year since it became the first country in the world to approve Pfizer's COVID-19 vaccine with a "Boost Day" call.

2 Dec 2021

Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

Researchers from Academia Sinica in Taiwan have been investigating new antibodies that could have strong effects against SARS-CoV-2 infection.

2 Dec 2021

Freeze-dried liposomes could be used in potential COVID-19 vaccines

Things that are freeze-dried: Astronaut food. Emergency rations. And, just maybe, some future COVID-19 vaccines.

1 Dec 2021

Pandemic may have impaired people's cognitive abilities and altered risk perception

The COVID-19 pandemic has tested our psychological limits. Some have been more affected than others by the stress of potential illness and the confusion of constantly changing health information and new restrictions.

1 Dec 2021

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

A recent study describes the association between time elapsed since the second dose of the Pfizer-BioNTech BNT162b2 vaccine and risk of COVID-19.

1 Dec 2021

Single-dose HPV vaccine could be effective for preventing cervical cancer

A single dose of human papillomavirus (HPV) vaccine could be effective for preventing cervical cancer, raising hopes of fighting the disease in Sub-Saharan Africa, a conference has heard.

1 Dec 2021

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

New research suggests that a fourth dose of the mRNA-1273 vaccine in kidney transplant recipients improves Delta variant serum neutralization.

1 Dec 2021

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

A new study retrospectively estimates the effective transmission advantage of the Alpha variant as compared to other non-VOC lineages.

1 Dec 2021

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.

1 Dec 2021

Safety and immunogenicity of different COVID-19 booster vaccines

New study findings suggest that booster vaccination with an mRNA-based vaccine has the highest immunogenicity against the COVID-19 Delta variant.

1 Dec 2021

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

A team of researchers from UK and US institutions created a large panel of mAbs derived from memory B cells of convalescent Beta subjects to better understand the antigenic landscape of Beta.

1 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

Modeling emergence and dynamics of new COVID-19 variants in the UK

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

Link between tobacco product use and alcohol consumption with anti-SARS-CoV-2 antibody titers after BNT162b2 vaccine

£700 million will help hospitals across England tackle waiting lists and improve care

Government signs new contracts to secure the supply of vaccine stock in light of new variant

Most U.S. states failed to prioritize cancer patients for COVID-19 vaccine rollout

Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

‘Boost Day’ drive launches to mark one year since COVID-19 vaccine approval in the UK

Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

Freeze-dried liposomes could be used in potential COVID-19 vaccines

Pandemic may have impaired people's cognitive abilities and altered risk perception

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

Single-dose HPV vaccine could be effective for preventing cervical cancer

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

Safety and immunogenicity of different COVID-19 booster vaccines

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in